Fikretoglu D., Brunet A., Schmitz N., Guay S., Pedlar D. (2006). Posttraumatic stress disorder and treatment seeking in a nationally representative Canadian military sample, J Trauma Stress, 19(6), 847-58.

Goldberg K., Norman R., Hoch J., Schmitz N., Windell D., Brown T., Malla A. (2006). Impact of a specialized early intervention service for psychotic disorders on patient characteristics, service use, and hospital costs in a defined catchment area, Can J Psychiatry, 51(14), 895-903.

Joober R., Grizenko N., Sengupta S., Amor L. B., Schmitz N., Schwartz G., Karama S., Lageix P., Fathalli F., Torkaman-Zehi A., Stepanian M. T. (2006). Dopamine Transporter 3'-UTR VNTR Genotype and ADHD: a Pharmaco-Behavioural Genetic Study with Methylphenidate, Neuropsychopharmacology.

Joober R., Schmitz N., Malla A., Sengupta S., Karma S. (2006). Is olanzapine a brain-sparing medication?, Arch Gen Psychiatry, 63(11), 1292.

Malla A., Norman R., Schmitz N., Manchanda R., Bechard-Evans L., Takhar J., Haricharan R. (2006). Predictors of rate and time to remission in first-episode psychosis: a two-year outcome study, Psychol Med, 1-10.

Schmitz N., Thefeld W., Kruse J. (2006). Mental disorders and hypertension: factors associated with awareness and treatment of hypertension in the general population of Germany, Psychosom Med, 68(2), 246-52.

Sengupta S. M., Grizenko N., Schmitz N., Schwartz G., Ben Amor L., Bellingham J., de Guzman R., Polotskaia A., Ter Stepanian M., Thakur G., Joober R. (2006). COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD, J Am Acad Child Adolesc Psychiatry, 45(11), 1363-9.